A panel of international experts has issued new consensus guidance aimed at improving how patent ductus arteriosus (PDA)—a persistent fetal blood vessel—should be closed in extremely low birth weight (ELBW) infants. The recommendations, published in Pediatric Research, focus on bedside transcatheter closure, a strategy designed to reduce delays and complications associated with transporting fragile newborns to specialized procedure rooms.
In ELBW babies, PDA can trigger a cascade of problems including impaired lung development and hemodynamic instability. Yet traditional management options—ranging from watchful waiting to pharmacologic closure and, in some settings, surgical ligation—can be limited by uncertainty in effectiveness and heightened procedural risk. Bedside catheter-based closure seeks to address those constraints by combining minimally invasive device delivery with an environment optimized for neonatal stability.
The consensus emphasizes that bedside transcatheter closure can be performed when appropriate clinical criteria are met and when teams follow standardized protocols for imaging, access, device selection, and post-procedure monitoring. Particular attention is given to patient preparation, including careful assessment of respiratory status, vascular access suitability, and the infant’s overall tolerance for intervention.
Technically, the guidance highlights the need for accurate PDA characterization prior to device deployment, typically using echocardiography to define ductal anatomy and guide selection. The panel underscores that the procedural approach should be tailored to duct morphology, aiming to maximize closure while minimizing residual shunting, hemolysis, or vessel injury.
Device choice and sizing are treated as pivotal determinants of safety and efficacy. Experts recommend using data-driven selection based on duct dimensions and hemodynamic impact, rather than relying solely on gestational age or birth weight. They also stress operator experience and structured team workflows to reduce variability between centers.
After closure, the recommendations call for systematic surveillance for complications such as recurrence of PDA flow, obstruction of adjacent vessels, and changes in oxygenation or blood pressure. Clear escalation pathways are also described for infants who show incomplete closure or unexpected deterioration.
Overall, the expert consensus frames bedside transcatheter PDA closure as a potentially safer and more efficient alternative for ELBW infants when implemented under standardized, evidence-informed protocols. By focusing on technical execution and consistent monitoring, the authors aim to turn an advanced procedure into a reproducible clinical pathway.
Subject of Research: Patent ductus arteriosus (PDA) closure in extremely low birth weight infants
Article Title: Expert consensus on bedside transcatheter closure of patent ductus arteriosus in extremely low birth weight infants
Article References: Ewert, P., McNamara, P.J., Benson, L. et al. Expert consensus on bedside transcatheter closure of patent ductus arteriosus in extremely low birth weight infants. Pediatr Res (2026). https://doi.org/10.1038/s41390-026-04977-7
Image Credits: AI Generated
DOI: 10.1038/s41390-026-04977-7
Keywords: Patent ductus arteriosus; transcatheter closure; extremely low birth weight; neonatal cardiology; bedside procedure
Tags: bedside transcatheter PDA closureechocardiography-guided PDA closureextremely low birth weight infant PDA managementfetal blood vessel closure techniquesneonatal hemodynamic stabilityneonatal intensive care procedural innovationsneonatal minimally invasive proceduresneonatal vascular access protocolsPDA treatment in preterm infantspediatric cardiology consensus guidelinesrisks of surgical PDA ligationstandardized neonatal device deployment
